John K. Park
YOU?
Author Swipe
View article: Spinal CSF Leaks In Spontaneous Intracranial Hypotension: A Single-Institution Analysis of Incidence, Typology and Treatment Outcomes
Spinal CSF Leaks In Spontaneous Intracranial Hypotension: A Single-Institution Analysis of Incidence, Typology and Treatment Outcomes Open
Purpose To report incidence, typology and treatment outcomes of spinal CSF leaks in patients with spontaneous intracranial hypotension (SIH). Methods In this IRB approved study, SIH patients with myelogram-confirmed spinal CSF leak locatio…
View article: Data from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
Data from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies Open
Glioblastoma multiforme is the most common primary malignant brain tumor and despite treatment with surgery, radiation, and chemotherapy, the median survival of patients with glioblastoma multiforme is ∼1 year. Glioblastoma multiforme expl…
View article: Supplementary Figure 1 Legend from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
Supplementary Figure 1 Legend from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies Open
Supplementary Figure 1 Legend from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
View article: Supplementary Figure 1 from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
Supplementary Figure 1 from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies Open
Supplementary Figure 1 from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
View article: Supplementary Figure 1 from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
Supplementary Figure 1 from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies Open
Supplementary Figure 1 from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
View article: Data from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
Data from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies Open
Glioblastoma multiforme is the most common primary malignant brain tumor and despite treatment with surgery, radiation, and chemotherapy, the median survival of patients with glioblastoma multiforme is ∼1 year. Glioblastoma multiforme expl…
View article: Supplementary Figure 1 Legend from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
Supplementary Figure 1 Legend from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies Open
Supplementary Figure 1 Legend from Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
View article: Real-world experience with intravaginal culture using INVOCELL: an alternative model for infertility treatment
Real-world experience with intravaginal culture using INVOCELL: an alternative model for infertility treatment Open
This study of IVC using INVOCELL as an alternative model for infertility treatment confirms its utility as a viable alternative to standard incubator-based in vitro fertilization. The technology is compatible within the current framework o…